Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia
Details for Australian Patent Application No. 2002329387 (hide)
International Classifications
Event Publications
30 January 2003 Complete Application Filed
Priority application(s): 0209463.9 25.04.02 GB; 0121768.6 08.09.01 GB
19 June 2003 Application Open to Public Inspection
Published as AU-B-2002329387
7 June 2007 Application Accepted
Published as AU-B-2002329387
4 October 2007 Standard Patent Sealed
5 June 2008 Assignment Registered
AstraZeneca AB The patent has been assigned to Albireo AB
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002329388-IMPROVEMENTS IN OR RELATING TO A DEVICE FOR CLEANING TEETH
2002329386-Benzothiepine ileal bile acid transport inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser